- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03468491
The Additional Effect of Hallux Valgus Correction on Runners With First Ray Instability and Patellofemoral Pain Syndrome
August 12, 2024 updated by: National Yang Ming Chiao Tung University
The Additional Effect of First Metatarsophalangeal Joint Correction on Runners With First Ray Instability and Patellofemoral Pain Syndrome
The study purpose is to investigate the effectiveness of a program combining biomechanical taping with lower extremity neuromuscular exercises for runners with patellofemoral pain syndrome (PFPS) and hallux valgus
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This will be a single-blind, experimental study with two treatment groups.
A total of 30 college athletes with PFPS and hallux valgus and majoring in long distance running or soccer, or recreational runners in Taipei metropolitan area will be recruited.
A set of clinical examination will be conducted to rule out abnormal knee structures, pathologies, or injuries apart from PFPS.
The lower extremity alignment as well as hip and knee kinematics during a step down test will be tracked using Noraxon's myoMOTION system.
Muscle activation of the muscles controlling the hip and knee movements during the step down test will be recorded using TELEmyo DTS of Noraxon.
Hallux valgus angle will be measured with surface markers on photographs.
Knee pain level will be rated in a visual analog scale.
The investigators will analyze the data with Statistical Product and Service Solutions (SPSS) for Windows.
Repeated-measure ANOVAs will be used to examine group-by-time interaction on all the outcome variables.
All significance level will be set at 0.05.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
北投區
-
Taipei City, 北投區, Taiwan, 112
- National Yng Ming University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- High physical activity level (running at least 5 times/week and at least 2 hours/time)
- Presenting anterior/retropatellar knee pain in the past 6 months
- At least two of the following activities provocated symptom: Prolonged sitting, ascending and/or descending stairs, squatting, kneeling, running, limping
- Not having any pathologies of knee joint (ligament tear, menisci injury, patellofemoral joint dislocation, tendinitis, bursitis…etc.)
- With hallux valgus angle>15°
- With 1st metatarsophalangeal joint instability
- 20~40 y/o
Exclusion Criteria:
- Lower extremities osteoarthritis
- Systematic diseases such as rheumatoid arthritis, systemic lupus erythematosus, DM…etc.
- Lower extremities fracture history
- Surgical history of lower extremities
- Neurological pathology that would interfere with gait
- Hallux could not be corrected to neutral through passive correction
- Low back pain and/or sacroiliac joint dysfunction in the past six months
- Excessive femoral anteversion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Combined training group
Biomechanical taping will first being applied to the participants of the combined training group.
They will be asked to perform following exercises in this session afterwards.
As the treatment session goes on, a set of foot intrinsic muscle strengthening exercise and lower extremity neuromuscular exercise will be provided.
|
The whole intervention period will last for 6 weeks, 2 visits per week, 1 hour per visit in the Research Building Room 630 of National Yang Ming University.
All programs will be under the supervision of a physiotherapist with 2-year experience individually.
1. Hallux valgus correction: 1.1 Joint alignment correction (Grade II joint mobilization, 10 times/set, 3 sets/visit) - 1st MTP joint distraction - Proximal talofibular joint anteroposterior glide - (Grade III joint mobilization if any restriction being found) 1.2 Biomechanical taping (using Dynamic taping, 1 time/ visit, keep the taping for 2 days minimum) 1.3 Foot intrinsic muscle strengthening (10 times/set for each exercise, 3 sets/visit): - Short foot exercise - Toespread out exercise - Heel-rise exercises 2. Lower extremity neuromuscular exercises: (10-15 times/set, 3 sets/visit) 2.1 Single lunge 2.2 Stepping down 2.3 Vertical squat 2.4 Vertical jumping
Other Names:
|
|
Active Comparator: Proximal training group
For participants of the proximal training group, only a set of lower extremity neuromuscular exercise will be provided.
This set of exercises is designed to be the same as for participants of combined training group.
|
1. Lower extremity neuromuscular exercises: (10-15 times/set, 3 sets/visit) 1.1 Single lunge 1.2 Stepping down 1.3 Vertical squat 1.4 Vertical jumping All exercises will first start on firm surface without additional resistance/weight.
Later, settings will be gradually shifted into on firm surface with resisted band from random direction, on a cushion with/ without resisted band, on a BOSU balance trainer.
Progression are made every 2 weeks ideally, while adjustments may be taken into concern due to individual differences.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Displacement of femur in step-down test
Time Frame: changes from baseline and after 6 weeks of intervention
|
displacement recorded in cm/BMI
|
changes from baseline and after 6 weeks of intervention
|
|
Displacement of tibia in step-down test
Time Frame: changes from baseline and after 6 weeks of intervention
|
displacement recorded in cm/BMI
|
changes from baseline and after 6 weeks of intervention
|
|
Knee pain level
Time Frame: changes from baseline and after 6 weeks of intervention
|
The level of knee pain during daily activities will be quantified with visual analogue scale.
|
changes from baseline and after 6 weeks of intervention
|
|
Changes of pain-free running distance
Time Frame: changes from baseline and after 6 weeks of intervention
|
The changes of pain-free running distance will be recorded in kilometers.
|
changes from baseline and after 6 weeks of intervention
|
|
EMG amplitude of knee extensor
Time Frame: changes from baseline and after 6 weeks of intervention
|
amplitude recorded in %MVC
|
changes from baseline and after 6 weeks of intervention
|
|
EMG amplitude of knee flexor
Time Frame: changes from baseline and after 6 weeks of intervention
|
amplitude recorded in %MVC
|
changes from baseline and after 6 weeks of intervention
|
|
EMG amplitude of hip external rotator
Time Frame: changes from baseline and after 6 weeks of intervention
|
amplitude recorded in %MVC
|
changes from baseline and after 6 weeks of intervention
|
|
changes of the muscle activation time between vastus medialis oblique and vastus lateralis
Time Frame: changes from baseline and after 6 weeks of intervention
|
changes of the muscle activation time recorded in second
|
changes from baseline and after 6 weeks of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tibiofemoral angle in relaxed standing
Time Frame: changes from baseline and after 6 weeks of intervention
|
recorded in degree
|
changes from baseline and after 6 weeks of intervention
|
|
Hallux valgus angle in relaxed standing
Time Frame: changes from baseline and after 6 weeks of intervention
|
recorded in degree
|
changes from baseline and after 6 weeks of intervention
|
|
Navicular drop
Time Frame: changes from baseline and after 6 weeks of intervention
|
navicular position changes between sitting and relaxed standing, recording in cm
|
changes from baseline and after 6 weeks of intervention
|
|
Arch height index
Time Frame: changes from baseline and after 6 weeks of intervention
|
arch height in one leg standing, recording in the ratio of arch height and truncated foot length
|
changes from baseline and after 6 weeks of intervention
|
|
Hip rotation angle in relaxed standing
Time Frame: changes from baseline and after 6 weeks of intervention
|
recorded in degree
|
changes from baseline and after 6 weeks of intervention
|
|
Knee rotation angle in relaxed standing
Time Frame: changes from baseline and after 6 weeks of intervention
|
recorded in degree
|
changes from baseline and after 6 weeks of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: be945a7ts@gmail.com Chen, PhD, National Yang Ming Chiao Tung University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2018
Primary Completion (Actual)
September 30, 2018
Study Completion (Actual)
January 30, 2019
Study Registration Dates
First Submitted
February 6, 2018
First Submitted That Met QC Criteria
March 11, 2018
First Posted (Actual)
March 16, 2018
Study Record Updates
Last Update Posted (Actual)
August 13, 2024
Last Update Submitted That Met QC Criteria
August 12, 2024
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- YM106048F
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patellofemoral Pain Syndrome
-
University of North Carolina, Chapel HillCanadian Institutes of Health Research (CIHR)CompletedPatellofemoral Pain Syndrome | Patellofemoral Pain (PFPS) | Patellofemoral Pain | Patellofemoral Pain, PFPUnited States
-
Lauren EricksonAmerican College of Sports MedicineCompleted
-
Beijing Sport UniversityCompletedPatellofemoral PainChina
-
Boston Children's HospitalEnrolling by invitationPatellofemoral PainUnited States
-
Pamukkale UniversityNot yet recruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Ahram Canadian UniversityNot yet recruitingPatellofemoral Pain (PFPS)Egypt
-
Beijing Sport UniversityCompletedPatellofemoral Pain, PFPChina
-
Beijing Sport UniversityNot yet recruitingPatellofemoral Pain, PFP
-
Beijing Sport UniversityNot yet recruiting
-
Istanbul University - CerrahpasaRecruitingPatellofemoral Pain, PFPTurkey (Türkiye)
Clinical Trials on combined training
-
University of LisbonCompletedChronic Heart Failure | FragilityPortugal
-
Hospital de Clinicas de Porto AlegreCompletedDiabetes Mellitus, Type 2
-
Louisiana State University Health Sciences Center...Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedCentral Nervous System Diseases | Cerebral Palsy | Brain Damage, ChronicUnited States
-
Comenius UniversityActive, not recruiting
-
Universidade Federal do Rio Grande do NorteCompleted
-
Ankara Yildirim Beyazıt UniversityCompletedPhysical TherapyTurkey
-
University of the Basque Country (UPV/EHU)Red Salud Mental ArabaRecruitingResistant Depression, TreatmentSpain
-
University of Trás-os-Montes and Alto DouroCompletedLipid Metabolism Disorders | Sarcopenia | Osteoporosis | Overweight and Obesity | Personal Satisfaction | Hypertension With Complications and Secondary HypertensionPortugal
-
University of BarcelonaUniversity of Pittsburgh; Germans Trias i Pujol Hospital; Ministerio de Economía... and other collaboratorsCompletedAging | Cognitive Function 1, SocialSpain
-
Bezmialem Vakif UniversityUnknownMultiple Sclerosis, Relapsing-Remitting